Storing stem cells from the umbilical cord and placental tissue is an act of care for your child. These cells have the ability to differentiate into various cell types, making them of great therapeutic interest.
Umbilical cord stem cells are currently used in the treatment of more than 80 conditions affecting the blood and immune system, including various forms of anaemia, leukaemia, and lymphoma. By choosing to bank them, you ensure an immediately accessible biological resource is ready for your child and family in times of need, wherever clinically applicable.
Every birth is a unique moment. Stem cells from the umbilical cord and placenta represent a valuable biological resource that is normally discarded immediately after birth.
Do not miss this unique opportunity.
The collection of stem cells from the umbilical cord is a simple, safe and painless procedure performed immediately after birth.
It is completely painless for both mother and child, as the collection takes place only after the umbilical cord has been clamped and cut.
The birth process is not affected in any way, and no additional effort is required from you or your medical team.
Currently, up to 84 serious diseases are treated with umbilical cord blood stem cells.
These cells represent a biological resource that is already used in clinical practice today.
Their potential is the subject of intense research and may expand over time, opening up new potential applications based on the results of ongoing clinical trials; therefore, storing them today means having access to a biological resource that could be valuable in the future.
Swiss Stem Cells Biotech (SSCB), founded in 2005 in Lugano (Switzerland), is the only private Swiss biobank with FACT-NetCord accreditation and GMP certification.
In compliance with strict Swiss regulations, SSCB manages the cryopreservation of umbilical cord blood, umbilical cord tissue and placental tissue.
SSCB is the only private biobank in Switzerland that performs the entire process – from processing to cryopreservation – entirely within its own laboratories in Switzerland.
SSCB is also an institutional partner in a public-private hybrid bank project. It is the only private biobank recognized within the WMDA network (World Marrow Donor Association) and collaborates with leading healthcare institutions, including Inselspital Bern, renowned Swiss clinics, and the “Swiss Stem Cells Foundation”, with which it is actively involved in the development of new therapies.
The company guarantees the highest standards of quality and safety, reflecting the excellence and innovation of the Swiss biotechnology and pharmaceutical industry.
We have been active for over 20 years and we offer you:
They are merely local distributors of foreign groups.
Regarding processing: unlike major competitors, SSCB is regularly inspected by the competent authorities and audited every three years by independent FACT-NetCord auditors – a guarantee of the highest quality for all our customers.
SSCB is the only private biobank in Switzerland authorized to offer the hybrid banking model – thanks to its local presence and certifications.
This is made possible through a pilot project approved by the Federal Office of Public Health (FOPH), carried out in partnership with the following institutions:
With the hybrid biobank option, stem cells are stored for family use but can be donated upon request by the public registry.
In the event of a donation for transplantation, storage costs are reimbursed.
A decision that combines family protection and solidarity – with the final decision always remaining with the family.
Thousands of families have already sheltered their children's biological assets.
Our experts are available to answer all your questions about stem cell preservation. By filling out the form, one of our experts will contact you to address all your questions — with no obligation to purchase.
A Swiss biotechnology company specializing in the preservation of human cells and tissues.
